http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013150829-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-38 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58 |
| filingDate | 2012-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013150829-A |
| titleOfInvention | VIRAL REPLICATION INHIBITORS, METHOD FOR PRODUCING THERAPY AND THERAPEUTIC USE |
| abstract | 1. The compound of formula (A): where: - W means a substituted, partially or completely unsaturated, aromatic or non-aromatic carbocycle or heterocycle; - a, b, c, d, e, f, g and h independently mean 0 or 1; - Q means CR, CR, CRRN, NR, NR, S, O, C = O, C = S, N = O, S = O, S (O); - Q means CR, CR, CRR, N, NR, NR, S, O, C = O, C = S, N = O, S = O, S (O); - Q means CR, CR, CRR, N, NR, NR, S, O, C = O, C = S , N = O, S = O, S (O); - Q means CR, CR, CRR, N, NR, NR, S, O, C = O, C = S, N = O, S = O, S ( O); - R, R, R, R, R, R, R and R are independently hydrogen, -CN, -OH, -O-cycloalkyl, -O-cycloalkenyl, -O-cycloalkynyl, -NH, -NR-cycloalkyl, -NR-cycloalkenyl, -NR-cycloalkynyl, -S-cycloalkyl, -S-cycloalkenyl, -S-cycloalkenyl, -COOH , -C (O) NH, -CF, -SONH, -NHSONH, -NHC (O) NH, -OC (O) NH, halogen, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, -O- aryl, -NR-aryl, -S-aryl, arylalkyl, arylalkenyl, arylalkynyl, arylheteroalkyl, arylheteroalkenyl, arylheteroalkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, heterocycle, -O-heterocyclo, -NR-heterocyclo , heterocyclyl alkenyl, heterocyclyl alkynyl, heterocyclyl heteroalkyl, heterocyclyl heteroalkenyl, heterocyclyl heteroalkynyl, unsubstituted or substituted by at least one T, where a carbon atom or the heteroatom of the given alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, aryl, arylalkyl, arylalkenyl, arylalkynyl, arylheteroalkyl, arylheteroalkenyl, arylheteroalkyl, heterocycloalkylalkyl, cycloalkyl, cycloalkyl, heteroalkyl, heterocyclyl heteroalkenyl, heterocyclyl heteroalkynyl can be oxidized to form C = O, C = S, N = O, N = S, S = O or S (O), and where the group is aryl, arylalkyl, arylalkenyl, arylalkynyl, aryl heteroalkyl and |
| priorityDate | 2011-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.